» Articles » PMID: 8750912

Crosstalk Between Thrombin and Adenylyl Cyclase-stimulating Agonists in Proliferating Human Erythroid Progenitor Cells

Overview
Specialty Pharmacology
Date 1995 Dec 1
PMID 8750912
Authors
Affiliations
Soon will be listed here.
Abstract

Human erythroid progenitor cells grown in a suspension culture system were used to study possible interactions between different guanine nucleotide-binding protein (G-protein)-coupled receptor-effector systems during normal cell differentiation. Agonist-stimulated adenylyl cyclase was not inhibited by any one of a panel of ligands (ADP, UTP, platelet-activating factor, thrombin, alpha2-adrenoceptor agonists, interleukin 8, lysophosphatidic acid) most of which are known, in other cells, to reduce cAMP formation by a Gi-mediated, pertussis toxin-sensitive mechanism. The first four of these ligands are also known to cause transient changes in intracellular [Ca2+] in erythroid cells. Rather than inhibiting, thrombin (but not ADP, UTP or PAF) specifically caused a fivefold increase in the maximum adenosine- or prostaglandin E1-stimulated cAMP formation, without any shift of the concentration/response curves. Thrombin did not enhance forskolin- and AlF4-stimulated cyclase activity and had only a marginal effect on isoprenaline-dependent stimulation. The effect of thrombin seemed to be unrelated to intracellular Ca2+ release but could be partially mimicked by phorbol ester (PMA)-induced stimulation of protein kinase C (PKC) and was inhibited by staurosporin or by inactivation of PKC after long-term incubation with PMA. The activity of thrombin was restricted to proliferating, colony-forming progenitor cells while proerythroblasts were completely unresponsive. Our results suggest that the interaction of thrombin with Gs-linked receptors requires phosphorylation of a target protein that is different from adenylyl cyclase, Gs or Gi but may be involved in the regulation of receptor desensitization.

References
1.
Seifert R, Schultz G . Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmacol Sci. 1989; 10(9):365-9. DOI: 10.1016/0165-6147(89)90009-6. View

2.
Hourani S, Hall D . Receptors for ADP on human blood platelets. Trends Pharmacol Sci. 1994; 15(4):103-8. DOI: 10.1016/0165-6147(94)90045-0. View

3.
Michel M . Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol Sci. 1991; 12(10):389-94. DOI: 10.1016/0165-6147(91)90610-5. View

4.
Miller B, Foster K, Robishaw J, Whitfield C, Bell L, Cheung J . Role of pertussis toxin-sensitive guanosine triphosphate-binding proteins in the response of erythroblasts to erythropoietin. Blood. 1991; 77(3):486-92. View

5.
Berenson R, Bensinger W, Kalamasz D, MARTIN P . Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption. Blood. 1986; 67(2):509-15. View